IBI-306

URI: https://gptkb.org/entity/IBI-306
GPTKB entity
Statements (12)
Predicate Object
gptkbp:instanceOf gptkb:monoclonal_antibody
gptkbp:alternativeName gptkb:tafolecimab
gptkbp:clinicalTrialPhase Phase 3
gptkbp:countryOfOrigin gptkb:China
gptkbp:developedBy gptkb:Innovent_Biologics
https://www.w3.org/2000/01/rdf-schema#label IBI-306
gptkbp:intendedUse gptkb:familial_hypercholesterolemia
gptkbp:mechanismOfAction PCSK9 inhibitor
gptkbp:routeOfAdministration intravenous
gptkbp:target gptkb:PCSK9
gptkbp:bfsParent gptkb:Suzhou_Innovent_Biologics
gptkbp:bfsLayer 7